Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said. Angelini is working with advisers as it studies a possible purchase of US-listed Catalyst, the people said. Family-owned Angelini has been reviewing other potential acquisition targets as well, and there’s no certainty the deliberations will lead to a transaction, the people said. Catalyst could also attract interest from other suitors.
Read the full article: Italy’s Angelini Said to Explore Catalyst Pharma Acquisition //
Source: https://www.msn.com/en-us/money/companies/italy-s-angelini-said-to-explore-catalyst-pharma-acquisition/ar-AA21Q5hz